/
/
ERC

ERC

Researchers of any nationality with 2-7 years of experience since completion of PhD, a scientific track record showing great promise and an excellent research proposal can apply. Applications can be made in any field of research.

Starting Grants may be awarded up to € 1.5 million for a period of 5 years. (pro rata for projects of shorter duration). However, an additional € 1 million can be made available to cover eligible “start-up” costs for researchers moving from a third country to the EU or an associated country and/or the purchase of major equipment and/or access to large facilities and/or other major experimental and field work costs.

Consolidator Grant

For a scientists who wants to consolidate independence by establishing a research team and continuing to develop a success career in Europe?

Who can apply – Researchers of any nationality with 7-12 years of experience since completion of PhD, a scientific track record showing great promise and an excellent research proposal can apply.

Consolidator Grants may be awarded up to € 2 million for a period of 5 years. (pro rata for projects of shorter duration).

Are you a researcher that wants to address a research problem so ambitious, that can not be dealt with you and your team alone? The Synergy Grants could be for you!

Who can apply? A group of two to maximum four Principal Investigators (PIs) working together and bringing different skills and resources to tackle ambitious research problems. One will be designated as the corresponding PI (cPI).

No specific eligibility criteria regarding the academic training are foreseen for ERC Synergy Grants. PIs must present a competitive track record as appropriate to their career stage. Proposals are evaluated on the sole criterion of scientific excellence which takes on the additional meaning of outstanding intrinsic synergetic effect.

Applications can be made in any field of research.

Synergy Grants can be up to a maximum of € 10 million for a period of 6 years (pro rata for projects of shorter duration).

However, an additional € 4 million can be requested in the proposal in total to cover eligible “start-up” costs for researchers moving from a third country to the EU or an associated country and/or the purchase of major equipment and/or access to large facilities and/or other major experimental and field work costs.

Criteria – The ERC Proof of Concept funding is made available only to those who already have an ERC award (that has ended after 1 January 2024,) to establish proof of concept of an idea that was generated in the course of their ERC-funded projects.

The Principal Investigator must be able to demonstrate the relation between the idea to be taken to proof of concept and the ERC frontier research project (Starting, Consolidator, Advanced or Synergy) in question

Work Programme 2024 will continue to award Proof of Concept Grants on the basis of a lump sum of EUR 150,000 for a period of 18 months.

Share this post

Facebook
Twitter
LinkedIn
WhatsApp

Latest Updates

mic

Bridge Funding for Disrupted Neurodegenerative Research Grant Program (BFDN) Powering the Next Generation of Research Objective: The Alzheimer’s Association and The Michael J. Fox Foundation...

Untitled-1

ASAP will support higher-risk, large-scale, ambitious projects across two tracks: scientific track and technical track. Scientific: an international, multidisciplinary, multi-institutional network of research teams working...

cur

Quarterly Research Grant Funding Programme We fund internationally and accept applications from academics and commercial entities. However, the costs in commercial applications should be justified...

parks

What is funded: Eligibility: Co-applicants and collaborators may be based at institutions outside the UK or at pharmaceutical or biotech companies. Grants are tenable only...

demoucelle

The Demoucelle Parkinson Charity partners with the Michael J. Fox Foundation for Parkinson’s Research and applies the following project selection criteria:

Frontespizio

We’re thrilled to share the latest publication from our Working Group 3 (WG3) at IMMUPARKNET COST Action 21117, published in npj Parkinson’s Disease! Entitled “Recommendations...